Bristol Myers reaches a crossroads as a make-or-break year takes shape

Chris Boerner, Bristol Myers Squibb CEO (Kevin Dietsch/Getty Images) April 29, 2026 11:33 AM EDT R&DPharmaIn Focus Bris­tol My­ers reach­es a cross­roads as a make-or-break year takes shape Max Gelman Senior Editor Bris­tol My­ers Squibb is fac­ing a bit of an iden­ti­ty cri­sis. CEO Chris Boern­er is near­ly two and a half years in­to his tenure, with … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER